Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biotronik reports positive long-term safety data for Dreams scaffold

Biotronik reports positive long-term safety data for Dreams scaffold

10th June 2013

Biotronik has announced data from the Biosolve-I study that underlines the positive safety performance of its drug-eluting absorbable metal scaffold Dreams.

Results showcased at the European Conference of Paris Course on Revascularisation revealed that no cardiac death or scaffold thrombosis incidents were observed among the 44 patients who received follow-up treatment in the study.

Meanwhile, target lesion failure rates at two years were stable at 6.8 percent compared to one year with no additional events.

The final scaffold design is now undergoing completion based on this data, with the final device to be investigated in a larger clinical study due to start by the end of the year.

Study investigator Professor Michael Haude said: "This uncaging effect seen in Dreams is expected to be one of the main benefits of bioabsorbable scaffolds, aiding them in avoiding chronic stress and inflammation and allowing for the positive remodeling of the vessel segment."

Last month, the firm completed enrolment for a new study that aims to demonstrate how its Home Monitoring system can improve outcomes for cardiac device patients.ADNFCR-8000103-ID-801597010-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.